JAFRAL is a global leading independent Contract Manufacturing Organization and Contract Research Organization for manufacturing different types of phage products. The company was established in 2011 and since then has successfully marketed phage manufacturing to many countries (UK, GER, US, FRA, CN, BEL, etc.). The application spectre varies from food industry, diagnostics, cosmetics, veterinary and human health. JAFRAL has worked with all pathogenic bacteria that WHO declared them most problematic (ESKAPE bacteria) and also many others. Some of them are: Listeria, Salmonella, Campylobacter, Propionibacterium, E.coli, Pseudomonas, Staphylococcus, Klebsiella and Clostridium. JAFRAL is works with natural and GMO phages.
Staphefekt focuses on the use of endolysins, bacteria-killing enzymes that originate from bacteriophages, to target Staphylococcus aureus and strains that are resistant to antibiotics, such as MRSA.
Terraflora Advanced Care uses a synbiotic approach of bacteriophages together with probiotics and prebiotics to provide an appropriate microbial balance and support for a healthy GI tract.